In recent years, tumour biomarkers such as p53, COX-2 (cyclooxygenase-2), Bax and Bcl-2 (B-cell lymphoma-2) have been widely used for early diagnosis, for monitoring and for the prognosis of canine mammary tumours [22,23,24]. The gene discussed is PTGS2; the disease is breast cancer.